Viking TherapeuticsDaniel Malowany2022-01-15T19:02:00+00:00 Project Description Follow-On Offering Common Stock . $175,800,000 Financial Advisor September 2018 Related Project Details Categories: IPO Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInTumblrPinterestVkEmail Related Projects